LLY

1,018.6

+0.41%↑

JNJ

195.64

+0.3%↑

ABBV

236.99

+1.61%↑

UNH

332.8

-2.01%↓

AZN

88.87

+0.69%↑

LLY

1,018.6

+0.41%↑

JNJ

195.64

+0.3%↑

ABBV

236.99

+1.61%↑

UNH

332.8

-2.01%↓

AZN

88.87

+0.69%↑

LLY

1,018.6

+0.41%↑

JNJ

195.64

+0.3%↑

ABBV

236.99

+1.61%↑

UNH

332.8

-2.01%↓

AZN

88.87

+0.69%↑

LLY

1,018.6

+0.41%↑

JNJ

195.64

+0.3%↑

ABBV

236.99

+1.61%↑

UNH

332.8

-2.01%↓

AZN

88.87

+0.69%↑

LLY

1,018.6

+0.41%↑

JNJ

195.64

+0.3%↑

ABBV

236.99

+1.61%↑

UNH

332.8

-2.01%↓

AZN

88.87

+0.69%↑

Search

Simulations Plus Inc

Abierto

SectorSalud

17.04 -1.79

Resumen

Variación precio

24h

Actual

Mínimo

16.91

Máximo

17.43

Métricas clave

By Trading Economics

Ingresos

-70M

-67M

Ventas

-2.1M

20M

P/B

Media del Sector

48.528

105.69

Rentabilidad por dividendo

0.48

Margen de beneficio

-330.585

Empleados

243

EBITDA

327K

5.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

-7.67% downside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.37%

Próximas Ganancias

1 dic 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-5.6M

346M

Apertura anterior

18.83

Cierre anterior

17.04

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

182 / 374 Clasificación en Healthcare

Simulations Plus Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

12 nov 2025, 21:55 UTC

Ganancias

Xero Beats 1st Half Profit Expectations Despite Melio Margin Hit

12 nov 2025, 21:34 UTC

Ganancias

Cisco Systems Boosts Fiscal Year Outlook as 1Q Profit, Revenue Rise

12 nov 2025, 23:44 UTC

Charlas de Mercado

Nikkei May Trade in Range Amid Caution Over U.S. Econ -- Market Talk

12 nov 2025, 23:38 UTC

Charlas de Mercado

Gold Steady Ahead of Expected End to U.S. Government Shutdown -- Market Talk

12 nov 2025, 23:13 UTC

Ganancias

Samsung Fire & Marine Insurance 3Q Net Profit Largely Met FactSet-Compiled Consensus

12 nov 2025, 23:13 UTC

Ganancias

Samsung Fire & Marine Insurance 3Q Net KRW538.50B Vs. Net KRW554.56B >000810.SE

12 nov 2025, 23:13 UTC

Ganancias

Samsung Fire & Marine Insurance 3Q Oper Pft KRW664.06B Vs. Pft KRW717.46B >000810.SE

12 nov 2025, 23:13 UTC

Ganancias

Samsung Fire & Marine Insurance 3Q Rev KRW5.732T Vs. KRW5.326T >000810.SE

12 nov 2025, 22:30 UTC

Charlas de Mercado
Ganancias

Firefly Aerospace Sets Plan for Next Launch After Explosion -- Market Talk

12 nov 2025, 22:18 UTC

Ganancias

Cisco Systems Boosts Outlook on AI-Driven Demand -- Update

12 nov 2025, 22:12 UTC

Charlas de Mercado

Bank of Canada Rate Hikes Could Start in 2H 2026 -- Market Talk

12 nov 2025, 22:05 UTC

Ganancias

Pan American Silver: Campbell Succeeded Steve Busby >PAAS

12 nov 2025, 22:04 UTC

Ganancias

Pan American Silver Named Scott Campbell as Operating Chief on Oct. 20

12 nov 2025, 22:04 UTC

Ganancias

Pan American Silver 3Q Adj EPS 48c >PAAS

12 nov 2025, 22:04 UTC

Ganancias

Pan American Silver 3Q Rev $884.4M >PAAS

12 nov 2025, 22:04 UTC

Ganancias

Pan American Silver 3Q EPS 45c >PAAS

12 nov 2025, 22:03 UTC

Ganancias

Manulife Financial: 3Q Book Value Per Common Shr C$26.07 >MFC.T

12 nov 2025, 22:02 UTC

Ganancias

Manulife Financial 3Q Net C$1.8B >MFC

12 nov 2025, 22:02 UTC

Ganancias

Manulife Financial 3Q Adj EPS C$1.16 >MFC

12 nov 2025, 22:02 UTC

Ganancias

Manulife Financial 3Q EPS C$1.02 >MFC

12 nov 2025, 21:53 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel: Sale Strengthens Focus on Own Growth Investments

12 nov 2025, 21:53 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Says Deal Subject to Indian Regulatory Approvals

12 nov 2025, 21:53 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Estimates Net Profit After Tax on Sale of A$70 Million

12 nov 2025, 21:53 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Expects Net Proceeds After Taxes, Fees of A$179 Million in 2H FY26

12 nov 2025, 21:52 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel: Tata BlueScope Steel JV a Provider of Coated, Painted Steel Products in India

12 nov 2025, 21:51 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Agrees to Sell 50% Stake in Tata BlueScope Steel Joint Venture to Tata Steel

12 nov 2025, 21:50 UTC

Charlas de Mercado
Ganancias

Basic Materials Roundup: Market Talk

12 nov 2025, 21:49 UTC

Ganancias

Cisco Stock Climbs as Earnings Beat Expectations Amid Strong AI Demand -- Barrons.com

12 nov 2025, 21:48 UTC

Ganancias

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares. -- Barrons.com

12 nov 2025, 21:40 UTC

Ganancias

Xero Beats 1H Profit Expectations Despite Melio Margin Hit

Comparación entre iguales

Cambio de precio

Simulations Plus Inc Esperado

Precio Objetivo

By TipRanks

-7.67% caída

Estimación a 12 meses

Media 16 USD  -7.67%

Máximo 16 USD

Mínimo 16 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

182 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat